Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:06 pm Sale | 2025-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | ORBIMED ADVISORS LLC | 3,230,797 2.600% | -207,016 (-6.02%) | Filing History |
| 2026-02-11 6:42 pm Sale | 2026-02-05 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 3,637,887 7.700% | -365,000 (-9.12%) | Filing History |
| 2026-01-27 8:38 pm Sale | 2026-01-23 | 13D | CORVUS PHARMACEUTICALS INC CRVS | ORBIMED ADVISORS LLC | 8,609,091 10.300% | -1,176,332 (-12.02%) | Filing History |
| 2025-11-14 6:18 pm Sale | 2025-09-30 | 13G | RAPT THERAPEUTICS INC RAPT | ORBIMED ADVISORS LLC | 1,086,618 6.600% | -555,290 (-33.82%) | Filing History |
| 2025-11-14 6:12 pm Unchanged | 2025-09-30 | 13G | INSPIREMD INC NSPR | ORBIMED ADVISORS LLC | 2,133,405 4.100% | 0 (Unchanged) | Filing History |
| 2025-11-14 6:08 pm Sale | 2025-09-30 | 13G | C4 THERAPEUTICS INC CCCC | ORBIMED ADVISORS LLC | 3,568,346 5.000% | -1,087,254 (-23.35%) | Filing History |
| 2025-11-14 6:04 pm Purchase | 2025-09-30 | 13G | VISTAGEN THERAPEUTICS INC VTGN | ORBIMED ADVISORS LLC | 1,639,700 5.340% | 1,639,700 (New Position) | Filing History |
| 2025-11-05 4:13 pm Sale | 2025-11-03 | 13D | TERNS PHARMACEUTICALS INC TERN | ORBIMED ADVISORS LLC | 4,240,068 4.800% | -3,322,903 (-43.94%) | Filing History |
| 2025-10-27 5:12 pm Sale | 2025-10-23 | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 4,975,291 9.400% | -1,587,786 (-24.19%) | Filing History |
| 2025-10-10 7:55 pm Purchase | 2025-10-08 | 13D | ADICET BIO INC ACET | ORBIMED ADVISORS LLC | 923,287 9.600% | 312,500 (+51.16%) | Filing History |
| 2025-09-30 7:06 pm Purchase | 2025-09-26 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 4,002,887 9.000% | 190,672 (+5.00%) | Filing History |
| 2025-09-02 9:53 pm Purchase | 2025-08-25 | 13D | SHATTUCK LABS INC STTK | ORBIMED ADVISORS LLC | 6,306,127 9.990% | 6,306,127 (New Position) | Filing History |
| 2025-08-15 5:28 pm Unchanged | 2025-08-13 | 13D | COMPASS THERAPEUTICS INC CMPX | ORBIMED ADVISORS LLC | 15,219,994 8.900% | 0 (Unchanged) | Filing History |
| 2025-08-14 6:07 pm Purchase | 2025-06-30 | 13G | CYTOMX THERAPEUTICS INC CTMX | ORBIMED ADVISORS LLC | 8,461,500 5.400% | 8,461,500 (New Position) | Filing History |
| 2025-08-14 6:03 pm Sale | 2025-06-30 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 2,614,184 8.000% | -792,151 (-23.26%) | Filing History |
| 2025-08-14 6:00 pm Sale | 2025-06-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | ORBIMED ADVISORS LLC | 967,000 8.900% | -1,958,900 (-66.95%) | Filing History |
| 2025-08-14 5:56 pm Sale | 2025-06-30 | 13G | VERASTEM INC VSTM | ORBIMED ADVISORS LLC | 1,333,333 2.400% | -1,529,115 (-53.42%) | Filing History |
| 2025-08-14 5:53 pm Sale | 2025-06-30 | 13G | X4 PHARMACEUTICALS INC XFOR | ORBIMED ADVISORS LLC | 134,947 1.700% | -248,201 (-64.78%) | Filing History |
| 2025-08-13 7:43 pm Unchanged | 2025-08-11 | 13D | ARRIVENT BIOPHARMA INC AVBP | ORBIMED ADVISORS LLC | 3,027,328 7.500% | 0 (Unchanged) | Filing History |
| 2025-07-30 9:28 pm Purchase | 2025-07-25 | 13D | IKENA ONCOLOGY INC IKNA | ORBIMED ADVISORS LLC | 773,754 6.920% | 106,345 (+15.93%) | Filing History |